Wan Jianmei, Zou Shitao, Hu Mengshang, Zhu Ran, Xu Jiaying, Jiao Yang, Fan Saijun
School of Radiation Medicine and Protection, Medical College, Soochow University, Suzhou, Jiangsu 215123, P.R. China.
Oncology Institute, Wuxi Fourth People's Hospital, Wuxi, Jiangsu 214062, P.R. China.
Mol Med Rep. 2014 Jun;9(6):2321-7. doi: 10.3892/mmr.2014.2088. Epub 2014 Mar 28.
THO complex 1 (Thoc1) is a human nuclear matrix protein that binds to the retinoblastoma tumor suppressor retinoblastoma protein (pRb). While some studies suggest that Thoc1 has characteristics of a tumor suppressor protein, whether Thoc1 can inhibit lung cancer cell growth is not clear. In the present study, we observed that Thoc1 is lowly expressed in the lung cancer cell lines SPC-A1 and NCI-H1975. Then, we investigated the potential effects of Thoc1 on lung cancer cell proliferation, cell cycle and apoptosis after stable transfection of these lines with a Thoc1 expression vector. We found that overexpression of Thoc1 can inhibit cell proliferation, induce G2/M cell cycle arrest and promote apoptosis. Further investigation indicated that overexpression of Thoc1 is involved in the inhibition of cell cycle-related proteins cyclin A1 and B1 and of pro-apoptotic factors Bax and caspase-3. In vivo experiments showed that tumors overexpressing Thoc1 display a slower growth rate than the control xenografts and show reduced expression of the protein Ki-67, which localized on the nuclear membrane. Taken together, our data show that in lung cancer cells, Thoc1 inhibits cell growth through induction of cell cycle arrest and apoptosis. These results indicate that Thoc1 may be used as a novel therapeutic target for human lung cancer treatment.
THO复合体1(Thoc1)是一种人类核基质蛋白,可与视网膜母细胞瘤肿瘤抑制蛋白视网膜母细胞瘤蛋白(pRb)结合。虽然一些研究表明Thoc1具有肿瘤抑制蛋白的特征,但Thoc1是否能抑制肺癌细胞生长尚不清楚。在本研究中,我们观察到Thoc1在肺癌细胞系SPC-A1和NCI-H1975中低表达。然后,在用Thoc1表达载体稳定转染这些细胞系后,我们研究了Thoc1对肺癌细胞增殖、细胞周期和凋亡的潜在影响。我们发现Thoc1的过表达可以抑制细胞增殖,诱导G2/M期细胞周期阻滞并促进凋亡。进一步研究表明,Thoc1的过表达参与抑制细胞周期相关蛋白细胞周期蛋白A1和B1以及促凋亡因子Bax和半胱天冬酶-3。体内实验表明,过表达Thoc1的肿瘤比对照异种移植瘤生长速度更慢,并且位于核膜上的蛋白Ki-67表达降低。综上所述,我们的数据表明,在肺癌细胞中,Thoc1通过诱导细胞周期阻滞和凋亡来抑制细胞生长。这些结果表明,Thoc1可能用作人类肺癌治疗的新型治疗靶点。